Mrs. Andreea-Liana Bot Rachisan, Romania
Novel biomarkers predictive for graft dysfunction – a pilot study using machine learning prediction as an AI tool
Dr. Lena Brunkhorst, Germany
Infection-related hospitalizations in pediatric kidney transplant recipients: A comparative study with a non-transplanted cohort
Dr. Huib De Jong, Netherlands
Is there a difference in outcome between DCD and DBD donor kidneys in pediatric transplant recipients? A nationwide analysis
Dr. Vikas Dharnidharka, United States
Contemporary treatment responses of recurrent focal segmental glomerulosclerosis or steroid resistant nephrotic syndrome in children after kidney transplantation: Phase 2 of a multicenter electronic health record data analysis
Dr. Ilja Finkelberg, Germany
Application of MC4R Agonist Setmelanotide in two post-renal transplant patients with Bardet-Biedl Syndrome (BBS): Successful Reduction in Hyperphagia and BMI
Nele Kanzelmeyer, Germany
Development of non-human leukocyte antigens antibodies and their association with antibody-mediated rejection in pediatric kidney transplant recipients
Dr. Lucy McAvoy, United Kingdom
Positive impact on graft function with repeated courses of Bortezomib in antibody-mediated rejection in a pediatric renal transplant recipient
Mrs. JoAnn M Morey, United States
Long term outcomes of sirolimus based immunosuppression among haplotyped-matched pediatric living donor kidney transplant recipients
Helen Pizzo, United States
Low incidence of rejection and de novo donor-specific antibody formation following covid-19 vaccination or infection among pediatric kidney transplant recipients
Dr. Moran Plonsky Toder, Israel
Phenotypic expansion of CRB2-related disease in monozygotic twins with multisystem involvement and severe post-transplant complications: Case report and literature review
Dr. Haider Ali, Pakistan
Living donor liver transplantation outcomes in Pediatric patients with liver decompensation secondary to Budd-Chiari Syndrome: A single center experience.
Dr. Syed Muhammad Talha Bukhari, Pakistan
Auxiliary Partial Orthotopic Liver Transplantation (APOLT) in Pediatric Patients with Crigler-Najjar Syndrome: A Single-Center Experience
Dr. Luca della Volpe, Italy
Changes in plasma citrulline after liver transplantation in patients with inborn errors of metabolism: non-invasive recovery indicator of intestinal function?
Ms. Isabel González-Barba Neira, Spain
All roads lead to Rome: Aortohepatic conduits as an alternative source of arterial inflow in pediatric liver transplants
Dr. Weihao Li, Netherlands
One-year outcomes of hepatic artery stenosis after pediatric liver transplantation: Preliminary results from an international, multicenter, real-world registry
Dr. Małgorzata Markiewicz-Kijewska, Poland
Uncommon but Fatal: Early Immunological Complications After Pediatric Liver Transplantation and Their Impact on Survival
Prof. Kai Wang, People's Republic of China
From ascites to rejection: Further recognizing antibody mediated rejection in pediatric liver transplantation through case reports
Dr. Jianxin Xi, People's Republic of China
Perioperative efficacy study of recombinant humanized anti-CD25 monoclonal antibody for immunoinduction in pediatric liver transplant recipients
Ji Soo Kim, United Kingdom
Investigating the modifiable psychosocial variables influencing access to and outcomes after kidney transplantation in children: preliminary findings of a longitudinal study
Debra Lefkowitz, United States
The impact of social determinants of health on screening measure completion at the pediatric pre-transplant psychosocial evaluation
Mrs. Amy Andrews, New Zealand
Use of parenteral nutrition prior to heart transplantation for Protein-losing enteropathy related to Fontan circulation: patient and clinician perspectives at critical timepoints